Trichomonas vaginalis Metalloproteinase Induces mTOR Cleavage of SiHa Cells |
Quan, Juan-Hua
(Department of Gastroenterology, The Affiliated Hospital of Guangdong Medical College)
Choi, In-Wook (Department of Infection Biology, Chungnam National University School of Medicine) Yang, Jung-Bo (Department of Obstetrics and Gynecology, Chungnam National University Hospital) Zhou, Wei (Department of Infection Biology, Chungnam National University School of Medicine) Cha, Guang-Ho (Department of Infection Biology, Chungnam National University School of Medicine) Zhou, Yu (Department of Gastroenterology, The Affiliated Hospital of Guangdong Medical College) Ryu, Jae-Sook (Department of Environmental Biology and Medical Parasitology, Hanyang University College of Medicine) Lee, Young-Ha (Department of Infection Biology, Chungnam National University School of Medicine) |
1 | Van der Pol B. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention. Clin Infect Dis 2007; 44: 23-25. DOI ScienceOn |
2 | Gomez-Barrio A, Nogal-Ruiz JJ, Montero-Pereira D, Rodriguez-Gallego E, Romero-Fernandez E, Escario JA. Biological variability in clinical isolates of Trichomonas vaginalis. Mem Inst Oswaldo Cruz 2002; 97: 893-896. DOI |
3 | Poole DN, McClelland RS. Global epidemiology of Trichomonas vaginalis. Sex Transm Infect 2013; 89: 418-422. DOI |
4 | Arroyo R, Alderete JF. Trichomonas vaginalis surface proteinase activity is necessary for parasite adherence to epithelial cells. Infect Immun1989; 57: 2991-2997. |
5 | Hirt RP, Noel CJ, Sicheritz-Ponten T, Tachezy J, Fiori PL. Trichomonas vaginalis surface proteins: a view from the genome. Trends Parasitol 2007; 23: 540-547. DOI |
6 | Ma L, Meng Q, Cheng W, Sung Y, Tang P, Hu S, Yu J. Involvement of the GP63 protease in infection of Trichomonas vaginalis. Parasitol Res 2011; 109: 71-79. DOI |
7 | Sommer U, Costello CE, Hayes GR, Beach DH, Gilbert RO, Lucas JJ, Singh BN. Identification of Trichomonas vaginalis cysteine proteases that induce apoptosis in human vaginal epithelial cells. J Biol Chem 2005; 280: 23853-23860. DOI |
8 | Kulkarni MM, Olson CL, Engman DM, McGwire BS. Trypanosoma cruzi GP63 proteins undergo stage-specific differential posttranslational modification and are important for host cell infection. Infect Immun 2009; 77: 2193-2200. DOI |
9 | Joshi PB, Kelly BL, Kamhawi S, Sacks DL, McMaster WR. Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor. Mol Biochem Parasitol 2002; 120: 33-40. DOI |
10 | Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004; 18: 1926-1945. DOI ScienceOn |
11 | Dennis PB, Jaeschke A, Saitoh M, Fowler B, Kozma SC, Thomas G. Mammalian TOR: a homeostatic ATP sensor. Science 2001; 294: 1102-1105. DOI ScienceOn |
12 | Edinger AL, Thompson CB. Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol Biol Cell 2002; 13: 2276-2288. DOI |
13 | Jaramillo M, Gomez MA, Larsson O, Shio MT, Topisirovic I, Contreras I, Luxenburg R, Rosenfeld A, Colina R, McMaster RW, Olivier M, Costa-Mattioli M, Sonenberg N. Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection. Cell Host Microbe 2011; 9: 331-341. DOI |
14 | Cao W, Manicassamy S, Tang H, Kasturi SP, Pirani A, Murthy N, Pulendran B. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat Immunol 2008; 9: 1157-1164. DOI |
15 | Polivka J Jr, Janku F. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol Ther 2014; 142: 164-175. DOI |
16 | Alvarez-Sanchez ME, Avila-Gonzalez L, Becerril-Garcia C, Fattel-Facenda LV, Ortega-Lopez J, Arroyo R. A novel cysteine proteinase (CP65) of Trichomonas vaginalis involved in cytotoxicity. Microb Pathog 2000; 28: 193-202. DOI |
17 | Galbaugh T, Cerrito MG, Jose CC, Cutler ML. EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HC11 cell lactogenic differentiation. BMC Cell Biol 2006; 7: 34. DOI |
18 | Vignot S, Faivre S, Aguirre D, Raymond E. mTOR-targeted therapy of cancer with rapamycin derivatives. Ann Oncol 2005; 16: 525-537. DOI ScienceOn |
19 | Matte C, Descoteaux A. Disruption of the AKT/mTOR pathway by Leishmania major promastigotes. BMC Proceedings 2011; 5 (suppl 1): 44. |
20 | Isnard A, Shio MT, Olivier M. Impact of Leishmania metalloprotease GP63 on macrophage signaling. Front Cell Infect Microbiol 2012; 2: 72. |
21 | Slomovitz BM, Coleman RL. The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer. Clin Cancer Res 2012; 18: 5856-5864. DOI |
22 | Pathania AS, Guru SK, Verma MK, Sharma C, Abdullah ST, Malik F, Chandra S, Katoch M, Bhushan S. Disruption of the PI3K/AKT/mTOR signaling cascade and induction of apoptosis in HL-60 cells by an essential oil from Monarda citriodora. Food Chem Toxicol 2013; 62: 246-254. DOI |
23 |
Park KR, Nam D, Yun HM, Lee SG, Jang HJ, Sethi G, Cho SK, Ahn KS. |
![]() |